Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
OGEN similar filings
- 7 Aug 23 Oragenics, Inc. Announces Private Placement
- 5 Jun 23 Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM
- 10 Apr 23 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
- 3 Apr 23 Regulation FD Disclosure
- 14 Mar 23 Oragenics Announces Positive Results in Several Lantibiotics Compounds Against MRSA and VRE
- 8 Mar 23 Oragenics Appoints Janet Huffman as Chief Financial Officer
- 1 Mar 23 Oragenics Enters into an Exclusive Global License Agreement with Inspirevax to Develop Intranasal Covid Vaccine Candidate
Filing view
External links
Exhibit 99.1